CClinicalTrials.gg
CompletedNCT02147717ELAPPSUpdated Jul 25, 2017

Laser Acupuncture and Pain Management in Preterm Infants Undergoing Patent Ductus Arteriosus Ligation

An interventional study of Laser stimulation and Fake laser stimulation in Preterm Newborns, sponsored by Assistance Publique - Hôpitaux de Paris. Completed at 1 site in France. Open to participants aged 24 Weeks to 32 Weeks. Per ClinicalTrials.gov, last updated 2017-07-25.

Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
24 Weeks to 32 Weeks
Sex
All
01

Study summary

Prospective study, controlled, randomized, single-center, blinded, which aims to evaluate the effect of laser acupuncture in the treatment of perioperative pain during tracheal suction after patent ductus arteriosus ligation in preterm infants.

Read the detailed description

management of pain in preterm infants is essential because it is exposed to repetitive movements painful and invasive miners such as surgical treatment of the ductus arteriosus which is accompanied by respiratory instability, increased consumption analgesics. Acupuncture has shown its analgesic efficacy in numerous studies in children and adults. Acupuncture (laser) is a simple, fast method without side effect used in children, but no study exists on the effect of acupuncture in the treatment of perioperative pain in addition to pharmacologic agents in preterm infants. Hypothesis: acupuncture reduce pain and discomfort after surgery of the ductus arteriosus in preterm infants in addition to pharmacologic agents

Main objective:

Assessing the contribution of laser acupuncture on the pain management during endotracheal suctioning (ETS) after surgery ductus arteriosus in preterm infants

02

Conditions studied

  • Preterm Newborns

Keywords

  • preterm newborns
  • Transfontanellar ultrafast doppler
  • Acupuncture
  • perioperative pain
  • surgery of the ductus arteriosus
03

In context

Premature Birth

2,554 studies on the registry are indexed under Premature Birth; 498 are open to participants now.

This study's enrollment of 40 is below the median of 84 across 1,689 interventional studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,505 studies on the registry; 1,006 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
24 Weeks to 32 Weeks
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Preterm infant born between 24 +0 and 32 +6 j GA
  • Ductus arteriosus surgery scheduled in Robert Debré hospital
  • Informed consent of the holders of the exercise of parental authority
  • Child beneficiary of a social security scheme (excluding AME)

Exclusion criteria

Exclusion Criteria:

  • Obvious underlying disease (genetic, metabolic)
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Laser stimulation

    Laser stimulation plus opioid treatment before ETS. Low level laser acupuncture, 670 nm, 10Hz, 0,3 J per acupoint, 6 points per neonate (Zu san li, He Gu, Nei Guan) marquage CE, premio 30 laser duo de Sedatelec. Overall 3 minutes of treatment. This sequence will be repeated 4 times during the study (1 hour before surgery and every 12 hours after surgery)

    Device: Laser stimulation

  • Placebo comparator
    fake laser stimulation

    newborns have the same preparation procedure as the intervention to put them under the same conditions group. The laser pen is turned off, off-voltage

    Device: Fake laser stimulation

Interventions

  • DeviceLaser stimulation

    Infants will be divided in 2 groups: * Placebo group: Placebo (fake laser stimulation) plus opioid treatment before ETS * Experimental group: Laser stimulation plus opioid treatment before ETS. Low level laser acupuncture, 670 nm, 10Hz, 0,3 J per acupoint, 6 points per neonate (Zu san li, He Gu, Nei Guan) marquage CE, premio 30 laser duo de Sedatelec. Overall 3 minutes of treatment. This sequence will be repeated 4 times during the study (1 hour before surgery and every 12 hours after surgery)

  • DeviceFake laser stimulation

    newborns have the same preparation procedure as the intervention to put them under the same conditions group. The laser pen is turned off, off-voltage

06

What researchers measure

Primary outcomes

  1. Behavioral pain scale (COMFORT scale)

    Behavioral pain scale (COMFORT scale) studied at a painful procedure (endotracheal suctioning, ETS) with a regular assessment in perioperative. All the ETS will videotaped with a color digital camera by the research assistant.

    Time frame: 48 hours post-operative

Secondary outcomes

  1. Behavioral pain scale (DAN scale and EDIN scale)

    Behavioral pain scale during ETS (DAN scale) and after ETS (EDIN scale)

    Time frame: 48hours postoperative

  2. Consumption of morphine

    Consumption of morphine (cumulative mg / kg dose) from surgery to 48h postoperative

    Time frame: 48 hours postoperative

  3. Measurement of FIO2

    Measurement of FIO2, mode of mechanical ventilation after surgery

    Time frame: 48 hours postoperative

07

Study locations

1 site
  • Hôpital Robert Debré
    Paris, 75019, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 25, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02147717
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Responsible party
Sponsor
First posted
May 28, 2014
Start date
May 2014
Primary completion
May 2017
Completion
May 2017
Last update
Jul 25, 2017

Study contacts

Biran Valérie, PHD
principal investigator · APHP

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion